Institutions / Ishara Investments LP / Holdings

Ishara Investments LP

All holdings · as of Dec 31, 2025

Company	Class	Value	Shares	% of portfolio
Praxis Precision Medicines, Inc.	—	$11.79M	40,000	13.7%
Xeris Biopharma Holdings, Inc.	—	$6.28M	800,000	7.3%
BioMarin Pharmaceutical Inc	—	$5.94M	100,000	6.9%
AMICUS THERAPEUTICS INC	—	$5.13M	360,000	6.0%
ACADIA Pharmaceuticals Inc	—	$4.27M	160,000	5.0%
Annexon, Inc.	—	$3.77M	750,000	4.4%
Nuvation Bio Inc.NUVB	Common Stock	$3.58M	400,000	4.2%
BridgeBio Pharma, Inc.	—	$2.75M	36,000	3.2%
PTC Therapeutics Inc	—	$2.73M	36,000	3.2%
United Therapeutics Corp	—	$2.68M	5,500	3.1%
BIOCRYST PHARMACEUTICALS INC	—	$2.34M	300,000	2.7%
VAXCYTE, INC.	—	$2.31M	50,000	2.7%
GENMAB A/S	—	$2.16M	70,000	2.5%
Syndax Pharmaceuticals Inc	—	$2.10M	100,000	2.4%
Verastem, Inc.	—	$2.08M	270,000	2.4%
TARSUS PHARMACEUTICALS, INC.	—	$1.97M	24,000	2.3%
APOGEE ENTERPRISES, INC.	—	$1.89M	25,000	2.2%
Zentalis Pharmaceuticals, Inc.ZNTL	Common Stock	$1.78M	1,320,000	2.1%
INSMED INC	—	$1.74M	10,000	2.0%
Silence Therapeutics plcSLN	ADR	$1.46M	240,000	1.7%
Edgewise Therapeutics, Inc.	—	$1.44M	58,000	1.7%
Beam Therapeutics Inc.	—	$1.39M	50,000	1.6%
Oric Pharmaceuticals, Inc.	—	$1.31M	160,000	1.5%
Apellis Pharmaceuticals, Inc.	—	$1.26M	50,000	1.5%
Denali Therapeutics Inc.	—	$1.16M	70,000	1.3%
Ultragenyx Pharmaceutical Inc.	—	$1.15M	50,000	1.3%
ASCENDIS PHARMA A/S	—	$1.07M	5,000	1.2%
NEWAMSTERDAM PHARMA COMPANY	—	$1.05M	30,000	1.2%
LEXICON PHARMACEUTICALS, INC.LXRX	Common Stock	$1.01M	880,000	1.2%
Biohaven Ltd.	—	$993.5K	88,000	1.2%
Dianthus Therapeutics, Inc.	—	$989.0K	24,000	1.2%
NEKTAR THERAPEUTICS	—	$845.6K	20,000	1.0%
IMMATICS N.V	—	$840.0K	80,000	1.0%
AGIOS PHARMACEUTICALS, INC.	—	$816.6K	30,000	1.0%
Immunovant, Inc.IMVT	Common Stock	$762.6K	30,000	0.9%
Olema Pharmaceuticals, Inc.	—	$750.0K	30,000	0.9%
Arcutis Biotherapeutics, Inc.	—	$348.5K	12,000	0.4%